About Let’s Talk Clots’23
Thrombosis UK welcomes you to this annual conference held in support of World Thrombosis Day.
New for 2023, we are honoured to welcome global leaders in VTE to host afternoon Masterclasses across hot topics and updates in thrombosis.
Seeking network and collaboration? Then join the very popular sessions by UK leading professional bodies, national leaders and local Champions to pose questions and learn more on VTE implementation, Case Studies and challenging scenarios.
LTC’23 I open to all healthcare and allied professionals, providing accredited, free education accessible 24/7 from 10th October – 30th November ‘23 View agenda to see the comprehensive range of sessions and opportunities to discuss, question, share and learn.
Venous thromboembolism can affect anyone regardless of age, gender, race, or ethnicity
Studies of patients who die unexpectedly of pulmonary embolism reveal that they complained of nagging symptoms often for weeks before death related to pulmonary embolism.
1. Safi M, Rostami RT, Taherkhani M. Unusual presentation of a massive pulmonary embolism. J Tehran Heart Cent. 2011 Winter;6(1):41-4. Epub 2011 Feb 28. PMID: 23074604; PMCID: PMC3466862.
2. Kline JA, Runyon MS. Pulmonary embolism and deep venous thrombosis. In: Marx JA, Hockenberger RS, Walls RM, editors. Rosen’s Emergency Medicine Concepts and Clinical Practice. 6th ed. London: mosby; 2006. pp. 1368–1382
Invitation to submit your Poster.
We invite you to take this opportunity to share your research with thousands of colleagues registering for LTC’23.
Accepted Posters will be displayed within the LTC’23 platform and for viewing by registered attendees from October 10th - 30th November 2023, with opportunity to chat and send questions to the lead author.
Up to four submissions will be selected and invited to be presented live during the LTC’23 conference with opportunity to take questions and discussion from the audience.
For full information on how to submit your abstract and e-poster.
World Thrombosis Day (WTD) is an Award-Winning, Collaborative Global Movement
Thrombosis UK is proud to be part of this international campaign working devoted to shining a spotlight on the condition of thrombosis. It draws attention to the signs, symptoms and risk factors of thrombosis, a condition that contributes to the deaths of 1 in 4 people worldwide each year.
World Thrombosis Day is a year-long campaign that takes place on October 13 annually.
In 2023, World Thrombosis Day will celebrate its 10th anniversary.
The All of Us Research Program is a historic effort by the National Institutes of Health (NIH) to create one of the largest most diverse biomedical databases by collecting and studying data from at least one million people living in the United States. The database will help transform the future of health research by equipping researchers nationwide with expansive health data from diverse populations, especially those underrepresented in biomedical research. The dataset combines biological factors and social determinants on a large, inclusive scale.
Unlike research studies that focus on one disease or a specific group of people, the program is building a database that can inform thousands of studies on a variety of health conditions, improve understanding of health and disease, identify opportunities to reduce disparities, and enable more precise approaches to care. The initiative is guided by core values such as transparency, diversity, and keeping participant information secure. It will equip researchers to make discoveries that can enable more precise approaches to care.
Learn more about the All of Us Research Hub
MDT case studies in lower limb thrombosis – haematology and vascular surgery perspectives
LTC'23 Selected Poster Presentations
Sponsored Symposium – Cardinal Health
"PETS Trial: Examining the benefit of graduated compression stockings in the Prevention of vEnous Thromboembolism in low-risk Surgical patients: a multicentre cluster randomised controlled trial (PETS Trial)"
Endovascular management of PE
LTC Masterclass: Venous Thromboembolism and Gender-Inclusive Women's Health
PCCS Symposium: Diagnosis and management of DVT and PE with case studies, when to offer lifelong OAC and cancer-related VTE
Sponsored Symposium – Bayer Is all VTE management the same? – Patient Journey
Sponsored Symposium - Techdow: Low Molecular Weight Heparins Should Be Prescribed by Their Brand Name
Sponsored Session: Bayer Round Table Event Real Management of VTE – Case Studies
THRIVE - Study Update and Recruitment Details: (THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment)
Sponsored Symposium – G&N
Sponsored Symposium: AstraZeneca
UKCPA Symposium: DOACs in cancer associated thrombosis: Sub-group challenges and considerations
LTC Masterclass New learning in Cancer Associated Thrombosis
VTE Specialist Network Questions & Answers in VTE Prevention and Management
LTC Masterclass: News at XI: Moving beyond the direct oral anticoagulants
Sponsoring companies have had no input into the conference agenda, speaker selection or presentations with the exception of sponsored symposia sessions, for which the respective sponsoring company is fully responsible.
AstraZeneca has provided a sponsorship grant towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence, except for the AstraZeneca sponsored symposium presentation.
Bayer has provided a sponsorship towards this independent Programme. Bayer has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence, except for the Bayer sponsored symposia.